Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

Novartis

Novartis

  1. UPDATE 2-FDA OKs Corcept's hormone disorder drug
    Reuters logo Reuters 2 days ago

    He said the boxed warning will not affect the sales of the drug and expects Korlym to rake in $506 million in annual sales by 2016. There are currently no drugs approved to treat the disease in the United States, although Novartis recently got the...

  2. Novartis Blood-Pressure Drug to Carry Warning
    Wall Street Journal logo Wall Street Journal 2 days ago

    AG suffered a setback Friday as it was ordered to start printing safety warnings on the packaging of a hypertension drug, aliskiren, that the company had hoped would become a blockbuster. Europe's main drug regulator Friday said it has completed a...

  3. Reuters Pictures logo Reuters Pictures 1 month ago
    Pascal Brenneisen (C) Country President at Novartis Group Switzerland speaks next to Philippe Leuba (L) member of the government Canton Vaud and Christoph Brutschin member of the government Canton Basel-Stadt during a news conference on the preservation...

    Pascal Brenneisen (C) Country President at Novartis Group Switzerland speaks next to Philippe Leuba (L) member of the government Canton Vaud and Christoph Brutschin member of the government Canton Basel-Stadt during a news conference on the preservation... View Photo »

  4. The rumors that Novartis has signed a multimillion-dollar spokesperson deal with Paula Deen for a diabetes treatment are not true
    SOURCE: Detroit Free Press 1 month ago
  5. Novartis to revamp Rasilez label with safety risks
    FiercePharma logo FiercePharma 2 days ago

    Novartis also said it has written doctors around the world recommending against using Rasilez--which is sold in the U.S. as Tekturna--in patients with Type 2 diabetes if they're also receiving an ACE inhibitor or ARB. The company is also working with...

  6. "Smart Pills" Send Stats to Smartphones, But Hard to Swallow
    Mobiledia 2 days ago

    Developed by Californian start-up Proteus Medical and Swiss drugmaker Novartis, the "smart pill" includes a sensor that sends vitals like heart rate or glucose level to a skin patch worn by the patient. The skin patch then sends the information to the...

  7. Novartis Blood-Pressure Drug to Carry Warning
    Wall Street Journal logo Wall Street Journal 2 days ago

    Novartis had been hoping to build it into a big seller that would help replace revenue the company will lose when its widely used hypertension pill Diovan loses patent protection in Western markets late this year. The Swiss company will now revise the...

  8. Reuters Pictures logo Reuters Pictures 3 months ago
    Workers of a Swiss plant of U.S. chemical company Huntsman carry a banner during a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Huntsman, Swiss drugmaker Novartis AG and other companies. The...

    Workers of a Swiss plant of U.S. chemical company Huntsman carry a banner during a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Huntsman, Swiss drugmaker Novartis AG and other companies. The... View Photo »

  9. Novartis is not working with Ms. Deen.
    SOURCE: Detroit Free Press 1 month ago
  10. They Just Don't Get Novartis!
    YouTube Logo YouTube Videos 1 month ago
  11. New EU contraindication and warnings for Novartis's aliskiren
    Scrip News 2 days ago

    New EU contraindication and warnings for Novartis's aliskiren Today Alex Shimmings The CHMP wants changes to the labels of products containing Novartis's troubled anithypertensive aliskiren that will massively curtail its recommended patient...

  12. Novartis to Add Warnings to Rasilez Blood-Pressure Drug
    Bloomberg.com logo Bloomberg.com 2 days ago

    AG (NOVN) said it will add a warning to the label for its blood-pressure drug Rasilez in Europe to comply with a request from regulators. Novartis is changing the product information for Rasilez, sold in the U.S. as Tekturna, to say that the drug should...

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using Daylife platform, which helps you be more efficient and creative with content. It's designed for publishers, editors, and developers to build better content-based sites, services, and apps for clients and audiences. Learn More »

About Novartis

Wikipedia

Novartis International AG (NYSE: NVS) is a multinational pharmaceutical company based in Basel, Switzerland that manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), cyclosporin A (Neoral / Sandimmun), letrozole (Femara), methylphenidate... Full Article

Related Photos

COMMERCIAL IMAGE - In this photo taken by AP Images for Novartis Animal Health US, Mike Rowe poses with Axl after announcing a donation to Guardian Angels for Soldier's Pets, in partnership with Sentinel Flavor Tabs (milbemycyn oxime/lufenuron), at the USS Intrepid Sea, Air and Space...
Pause Play 1/17
prev
  1. COMMERCIAL IMAGE - In this photo taken by AP Images for Novartis Animal Health US, Mike Rowe poses with Axl after announcing a donation to Guardian Angels for Soldier's Pets, in partnership with Sentinel Flavor Tabs (milbemycyn oxime/lufenuron), at the USS Intrepid Sea, Air and Space... AP Photo logo AP Photo 5 months ago

    COMMERCIAL IMAGE - In this photo taken by AP Images for Novartis Animal Health US, Mike Rowe poses with Axl after announcing a donation to Guardian Angels for Soldier's Pets, in partnership with Sentinel Flavor Tabs (milbemycyn oxime/lufenuron), at the USS Intrepid Sea, Air and Space...

    View Photo »
  2. A tram crosses the Rhine River near the Novartis plant in Basel in this March 28, 2008 file photo. A strong franc not withstanding, the Swiss pharmaceuticals industry is still stepping up investments in Basel. After 500 years, executives say it will take more than a currency crisis to... Reuters Pictures logo Reuters Pictures 5 months ago

    A tram crosses the Rhine River near the Novartis plant in Basel in this March 28, 2008 file photo. A strong franc not withstanding, the Swiss pharmaceuticals industry is still stepping up investments in Basel. After 500 years, executives say it will take more than a currency crisis to...

    View Photo »
  3. A child looks at a model of the Novartis Campus, an international chemical research company in Basel, Switzerland and designed by Canadian-American architect Frank Gehry during a Gehry exhibition in Hong Kong on September 13, 2011. Gehry is a Pritzker Prize-winning architect based in... Getty Images logo Getty Images 5 months ago

    A child looks at a model of the Novartis Campus, an international chemical research company in Basel, Switzerland and designed by Canadian-American architect Frank Gehry during a Gehry exhibition in Hong Kong on September 13, 2011. Gehry is a Pritzker Prize-winning architect based in...

    View Photo »
  4. BEIJING, CHINA - MARCH 21: Joseph Jimenez, chief executive officer of Novartis AG, delivers a speech during the 12th China Development Forum at Diaoyutai National Guesthouse on March 21, 2011 in Beijing, China. The 12th China Development Forum runs from March 20 to 21 in Beijing with... Getty Images logo Getty Images 11 months ago

    BEIJING, CHINA - MARCH 21: Joseph Jimenez, chief executive officer of Novartis AG, delivers a speech during the 12th China Development Forum at Diaoyutai National Guesthouse on March 21, 2011 in Beijing, China. The 12th China Development Forum runs from March 20 to 21 in Beijing with...

    View Photo »
  5. A general view shows Swiss drugmaker Novartis headquarters in Basel September 1, 2011. Growth in emerging markets and trading the rich world up to more advanced implanted lenses are major untapped opportunities for Novartis's eyecare unit Alcon, Novartis's CEO Joe Jimenez told Reuters. ... Reuters Pictures logo Reuters Pictures 5 months ago

    A general view shows Swiss drugmaker Novartis headquarters in Basel September 1, 2011. Growth in emerging markets and trading the rich world up to more advanced implanted lenses are major untapped opportunities for Novartis's eyecare unit Alcon, Novartis's CEO Joe Jimenez told Reuters. ...

    View Photo »
  6. COMMERCIAL IMAGE - In this photo taken by AP Images for Novartis Animal Health US, Inc. , Mike Rowe, right, and his best friend Chuck, dressed as a lovable Burmese Mountain dog, are seen on the set of a Novartis Animal Health Sentinel (milbemycin oxime/lufenuron) Flavor Tabs shoot in Newhall,... AP Photo logo AP Photo 6 months ago

    COMMERCIAL IMAGE - In this photo taken by AP Images for Novartis Animal Health US, Inc. , Mike Rowe, right, and his best friend Chuck, dressed as a lovable Burmese Mountain dog, are seen on the set of a Novartis Animal Health Sentinel (milbemycin oxime/lufenuron) Flavor Tabs shoot in Newhall,...

    View Photo »
  7. File photo of people walking past the logo of Swiss drugmaker Novartis at the company's plant in Basel January 28, 2009. Novartis's half-year company results will be announced July 19, 2011. Reuters Pictures logo Reuters Pictures 7 months ago

    File photo of people walking past the logo of Swiss drugmaker Novartis at the company's plant in Basel January 28, 2009. Novartis's half-year company results will be announced July 19, 2011.

    View Photo »
  8. File photo of the logo of Swiss drugmaker Novartis on top of an office building at the company's plant in Basel January 28, 2009. Novartis's half-year company results will be announced July 19, 2011. Reuters Pictures logo Reuters Pictures 7 months ago

    File photo of the logo of Swiss drugmaker Novartis on top of an office building at the company's plant in Basel January 28, 2009. Novartis's half-year company results will be announced July 19, 2011.

    View Photo »
  9. Workers of a Swiss plant of U.S. chemical company Huntsman carry a banner during a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Huntsman, Swiss drugmaker Novartis AG and other companies. The banner is showing Walt Disney's... Reuters Pictures logo Reuters Pictures 3 months ago

    Workers of a Swiss plant of U.S. chemical company Huntsman carry a banner during a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Huntsman, Swiss drugmaker Novartis AG and other companies. The banner is showing Walt Disney's...

    View Photo »
  10. Swiss National Councillor Corrado Parini (R) makes a speech during a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Swiss drugmaker Novartis AG and other companies. Reuters Pictures logo Reuters Pictures 3 months ago

    Swiss National Councillor Corrado Parini (R) makes a speech during a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Swiss drugmaker Novartis AG and other companies.

    View Photo »
  11. People carry a banner and flags of the Swiss Unia union during a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Swiss drugmaker Novartis AG and other companies. The banner is reading: 'Protect jobs instead of maximizing profits !'. Reuters Pictures logo Reuters Pictures 3 months ago

    People carry a banner and flags of the Swiss Unia union during a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Swiss drugmaker Novartis AG and other companies. The banner is reading: 'Protect jobs instead of maximizing profits !'.

    View Photo »
  12. People carry banners and flags of the Swiss Unia union as they march past a Bentley luxury limousine during a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Swiss drugmaker Novartis AG and other companies. The banner is reading:... Reuters Pictures logo Reuters Pictures 3 months ago

    People carry banners and flags of the Swiss Unia union as they march past a Bentley luxury limousine during a demonstration in Basel October 29, 2011. Some thousand participants protested against planned job cuts at Swiss drugmaker Novartis AG and other companies. The banner is reading:...

    View Photo »
  13. A file picture shows the logo of Swiss drugmaker Novartis on the top of an office building at the company's plant in Basel January 28, 2009. Swiss drugmaker Novartis AG posted forecast-beating first-quarter sales April 19, 2011, thanks to robust demand for its newest drugs, and said its... Reuters Pictures logo Reuters Pictures 10 months ago

    A file picture shows the logo of Swiss drugmaker Novartis on the top of an office building at the company's plant in Basel January 28, 2009. Swiss drugmaker Novartis AG posted forecast-beating first-quarter sales April 19, 2011, thanks to robust demand for its newest drugs, and said its...

    View Photo »
  14. A file picture shows people walk past the logo of Swiss drugmaker Novartis at the company's plant in Basel January 28, 2009. Swiss drugmaker Novartis AG posted forecast-beating first-quarter sales April 19, 2011, thanks to robust demand for its newest drugs, and said its key new... Reuters Pictures logo Reuters Pictures 10 months ago

    A file picture shows people walk past the logo of Swiss drugmaker Novartis at the company's plant in Basel January 28, 2009. Swiss drugmaker Novartis AG posted forecast-beating first-quarter sales April 19, 2011, thanks to robust demand for its newest drugs, and said its key new...

    View Photo »
  15. Joseph Jimenez, CEO of Swiss pharmaceutical group Novartis, speaks during the extraordinary general assembly in Basel, Switzerland, Friday, April 8, 2011. Shareholders vote Friday on a US dollar 51 billion deal to buy Alcon eye care company. AP Photo logo AP Photo 10 months ago

    Joseph Jimenez, CEO of Swiss pharmaceutical group Novartis, speaks during the extraordinary general assembly in Basel, Switzerland, Friday, April 8, 2011. Shareholders vote Friday on a US dollar 51 billion deal to buy Alcon eye care company.

    View Photo »
  16. A pharmacist holds up a box of Distilbene (diéthylstilboestrol or DES), on September 24, 2009 in Paris. Women suffering from cancer after being exposed in utero to the drug will no longer have to prove which brand of the drug their mother took during pregnancy, a court ruled today. ... Getty Images logo Getty Images 10 months ago

    A pharmacist holds up a box of Distilbene (diéthylstilboestrol or DES), on September 24, 2009 in Paris. Women suffering from cancer after being exposed in utero to the drug will no longer have to prove which brand of the drug their mother took during pregnancy, a court ruled today. ...

    View Photo »
  17. The Glencore logo is seen on a sign in front of Swiss commodities trader Glencore building in Baar near Zurich January 5, 2010. In the world of physical trading - buying, transporting and selling the basic stuff the world needs - Glencore is omnipresent and controversial, just as... Reuters Pictures logo Reuters Pictures 11 months ago

    The Glencore logo is seen on a sign in front of Swiss commodities trader Glencore building in Baar near Zurich January 5, 2010. In the world of physical trading - buying, transporting and selling the basic stuff the world needs - Glencore is omnipresent and controversial, just as...

    View Photo »
next
AP Photo logo AP Photo 5 months ago

COMMERCIAL IMAGE - In this photo taken by AP Images for Novartis Animal Health US, Mike Rowe poses with Axl after announcing a donation to Guardian Angels for Soldier's Pets, in partnership with Sentinel Flavor Tabs (milbemycyn oxime/lufenuron), at the USS Intrepid Sea, Air and Space...

View Photo »
View All »

Related Topics

  1. Diabetes Diabetes
  2. Paula Deen Paula Deen
  3. Pfizer Inc. Pfizer Inc.
  4. AstraZeneca PLC AstraZeneca PLC
  5. Merck & Co.
  6. High Cholesterol High Cholesterol

Timeline of Coverage

  1. Click to see all coverage from Jan 04, 2012
    4
    January 04, 2012
  2. Click to see all coverage from Jan 05, 2012
    3
    January 05, 2012
  3. Click to see all coverage from Jan 06, 2012
    8
    January 06, 2012
  4. Click to see all coverage from Jan 07, 2012
    1
    January 07, 2012
  5. Click to see all coverage from Jan 08, 2012
    122
    January 08, 2012
  6. Click to see all coverage from Jan 09, 2012
    340
    January 09, 2012
  7. Click to see all coverage from Jan 10, 2012
    62
    January 10, 2012
  8. Click to see all coverage from Jan 11, 2012
    9
    January 11, 2012
  9. Click to see all coverage from Jan 12, 2012
    3
    January 12, 2012
  10. Click to see all coverage from Jan 13, 2012
    202
    January 13, 2012
  11. Click to see all coverage from Jan 14, 2012
    15
    January 14, 2012
  12. Click to see all coverage from Jan 15, 2012
    2
    January 15, 2012
  13. Click to see all coverage from Jan 16, 2012
    18
    January 16, 2012
  14. Click to see all coverage from Jan 17, 2012
    14
    January 17, 2012
  15. Click to see all coverage from Jan 18, 2012
    22
    January 18, 2012
  16. Click to see all coverage from Jan 19, 2012
    11
    January 19, 2012
  17. Click to see all coverage from Jan 20, 2012
    129
    January 20, 2012
  18. Click to see all coverage from Jan 21, 2012
    4
    January 21, 2012
  19. Click to see all coverage from Jan 22, 2012
    4
    January 22, 2012
  20. Click to see all coverage from Jan 23, 2012
    5
    January 23, 2012
  21. Click to see all coverage from Jan 24, 2012
    4
    January 24, 2012
  22. Click to see all coverage from Jan 25, 2012
    136
    January 25, 2012
  23. Click to see all coverage from Jan 26, 2012
    13
    January 26, 2012
  24. Click to see all coverage from Jan 27, 2012
    21
    January 27, 2012
  25. Click to see all coverage from Jan 28, 2012
    0
    January 28, 2012
  26. Click to see all coverage from Jan 29, 2012
    12
    January 29, 2012
  27. Click to see all coverage from Jan 30, 2012
    18
    January 30, 2012
  28. Click to see all coverage from Jan 31, 2012
    19
    January 31, 2012
  29. Click to see all coverage from Feb 01, 2012
    14
    February 01, 2012
  30. Click to see all coverage from Feb 02, 2012
    14
    February 02, 2012
  31. Click to see all coverage from Feb 03, 2012
    2
    February 03, 2012
  32. Click to see all coverage from Feb 04, 2012
    0
    February 04, 2012
  33. Click to see all coverage from Feb 05, 2012
    2
    February 05, 2012
  34. Click to see all coverage from Feb 06, 2012
    7
    February 06, 2012
  35. Click to see all coverage from Feb 07, 2012
    9
    February 07, 2012
  36. Click to see all coverage from Feb 08, 2012
    5
    February 08, 2012
  37. Click to see all coverage from Feb 09, 2012
    7
    February 09, 2012
  38. Click to see all coverage from Feb 10, 2012
    7
    February 10, 2012
  39. Click to see all coverage from Feb 11, 2012
    1
    February 11, 2012
  40. Click to see all coverage from Feb 12, 2012
    2
    February 12, 2012
  41. Click to see all coverage from Feb 13, 2012
    4
    February 13, 2012
  42. Click to see all coverage from Feb 14, 2012
    5
    February 14, 2012
  43. Click to see all coverage from Feb 15, 2012
    11
    February 15, 2012
  44. Click to see all coverage from Feb 16, 2012
    5
    February 16, 2012
  45. Click to see all coverage from Feb 17, 2012
    9
    February 17, 2012
  46. Click to see all coverage from Feb 18, 2012
    1
    February 18, 2012
  47. Click to see all coverage from Feb 19, 2012
    14
    February 19, 2012
  48. Click to see all coverage from Feb 20, 2012
    0
    February 20, 2012

Related Videos

  1. Videosurf
    1. Faber Report: Novartis Eyes Alcon
      Faber Report: Novartis Eyes Alcon
      25 months ago
    2. Business Update : Novartis buys Alcon
      Business Update : Novartis buys Alcon
      25 months ago
    3. Novartis flu jab
      Novartis flu jab
      29 months ago
    4. CNBC : Novartis Opens 1st US Plant for Flu Vaccine
      CNBC : Novartis Opens 1st US Plant for Flu Vaccine
      27 months ago
    5. CNBC : Novartis to Develop Vanda Schizophrenia Drug
      CNBC : Novartis to Develop Vanda Schizophrenia...
      28 months ago
    6. CNBC : Novartis CEO on Earnings
      CNBC : Novartis CEO on Earnings
      51 months ago
    View All Videosurf Videos »

Related Quotes

There are no results for this module. Edit the module to change the search term used to query related quotes.

We found no quotes related to Novartis.